Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Lupin Secures Tentative FDA Nod For Apixaban Oral Suspension
posted:
Mon, 09/28/2026 - 22:51 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
NeOnc Plans FDA Discussions On NEO212 Clinical Development And Potential Approval Pathway
posted:
Mon, 09/28/2026 - 12:57 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Bayer Gains FDA Priority Review For Lynkuet Label Expansion In Breast Cancer-Related Indication
posted:
Mon, 09/28/2026 - 10:14 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Bayer: FDA Grants Priority Review To Lynkuet For New Indication
posted:
Mon, 09/28/2026 - 08:31 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
AbbVie Announces FDA Approval Of JUVMO For Parkinson's Disease
posted:
Mon, 09/28/2026 - 08:18 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
CervoMed Advances Neflamapimod With New Tablet Formulation And FDA Dose Flexibility
posted:
Mon, 09/28/2026 - 07:54 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
XtalPi Submits FDA IND Application For KQTD-126 In Chronic Intestinal Pain
posted:
Mon, 09/28/2026 - 00:22 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
FDA Grants Priority Review To Genentech's Inavolisib For Advanced HR+, HER2- Breast Cancer Mutation
posted:
Wed, 05/29/2024 - 01:19 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Inspira Gets FDA 510(k) Clearance For Cardiopulmonary Bypass System; Stock Down
posted:
Tue, 05/28/2024 - 10:15 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
posted:
Mon, 05/27/2024 - 10:43 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Sanofi's Sarclisa Granted FDA Priority Review For Transplant-Ineligible Multiple Myeloma Treatment
posted:
Mon, 05/27/2024 - 01:24 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Roche: FDA Grants Breakthrough Device Designation For Bood Test Measuring Lp(a)
posted:
Wed, 05/22/2024 - 01:32 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Biocon Biologics: FDA Approves YESAFILI As First Interchangeable Biological Product To Eylea
posted:
Tue, 05/21/2024 - 08:17 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
SAB Biotherapeutics Gets FDA Clearance To Advance Phase 1 Trial Of SAB-142 In Type-1 Diabetes
posted:
Tue, 05/21/2024 - 08:07 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Amgen: FDA Approves Imdelltra For Extensive-Stage Small Cell Lung Cancer Treatment
posted:
Thu, 05/16/2024 - 21:01 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Pagination
Previous page
‹‹
Page 2
Next page
››